MarkNtel Advisors recently published a detailed industry analysis of the Global Cancer Gene Panel and Profiling. The report covers growth trends, geographical marketing strategies, challenges, opportunities, and drivers influencing the market.

Global Cancer Gene Panel and Profiling, Share, and Trends Analysis Report – Industry Overview and Forecast to 2029

The Cancer Gene Panel and Profiling Market is estimated to grow at a CAGR of around 15.5% during the forecast period, i.e., 2024-29.

Key Findings in Global Cancer Gene Panel and Profiling:

Historical Analysis: 2019–2022

Base Year: 2023

Forecast Period: 2024–2029

Leading Market Players-

10x Genomics, Inc., Caris Lifescience, Neo genomics, Flugent Genetics, Centogene N.V., Geneseeq Technology Inc., Variantyx, Genetron Holdings Limited, Laboratory Corporation of America® Holdings (LabCorp), H.T. G Molecular, Bio array Diagnostic genetic, Biorad laboratories Inc., Enzo Lifesciences, Eurofins Scientific, Nanostring Technologies, Other

Key Highlights of the Report

Market Dimensions & Projections

Pricing Evaluation,

Recent Strategic Moves by Companies,

Primary Stakeholders,

Analysis of Import and Export Trends,

Competitive Landscape Assessment,

Emerging Opportunities,

Market Trends and Indicators

What are the major Driver the Global Cancer Gene Panel and Profiling industry?

Growing Prevalence of Hereditary Cancer Cases Globally – The escalating prevalence of hereditary cancer occurrences on a global scale has amplified the demand for genetic panels & profiling testing within the market. This has been mainly because the cancer gene panel and profiling services are highly effective & accurate in the detection of hereditary cancer cases.

Also, genetic testing companies have started offering a comprehensive array of services, including advanced screening & diagnostics in recent years. As a result, there has been an increasing adoption of these testing services by research institutions & clinical laboratories engaged in detecting biomarkers of hereditary cancer cases. This robust adoption trajectory is a direct response to the persistent surge in hereditary cancer cases, as evidenced by historical trends. For instance:

In 2022, the National Cancer Institute indicated that approximately 10% of all cancer cases witnessed were attributable to hereditary genetic mutations.

As the mutations in hereditary cancer are only pinpointed to specific genes responsible for shielding the body against cancer, it led to genetic testing services coming up as a pivotal method of diagnosis. Notably, clinicians have embraced this technique with significant impact, thereby fostering substantial growth within the Cancer Gene Panel and Profiling Market.

Download now and gain valuable insights to inform your business strategy, drive growth, and stay ahead of the competition - Download Free PDF Sample- https://www.marknteladvisors.com/query/request-sample/cancer-gene-panel-profiling-market.html

What segments define the Global Cancer Gene Panel and Profiling from 2024 to 2029? How do these segments contribute to market dynamics and growth?

By Technology

Next-generation Sequencing (NGS)- Market Size & Forecast 2019-2029, USD Million

Polymerase Chain Reaction(PCR)- Market Size & Forecast 2019-2029, USD Million

Microarray- Market Size & Forecast 2019-2029, USD Million

Mass Spectrometry- Market Size & Forecast 2019-2029, USD Million

Others (Fluorescence in-situ hybridization, Immunohistochemistry, etc.)- Market Size & Forecast 2019-2029, USD Million

By Application

Oncology Research- Market Size & Forecast 2019-2029, USD Million

Personalized Medicine- Market Size & Forecast 2019-2029, USD Million

Drug Development- Market Size & Forecast 2019-2029, USD Million

Clinical Diagnostics- Market Size & Forecast 2019-2029, USD Million

By Cancer Type

Breast Cancer- Market Size & Forecast 2019-2029, USD Million

Lung Cancer- Market Size & Forecast 2019-2029, USD Million

Prostrate Cancer- Market Size & Forecast 2019-2029, USD Million

Colorectal Cancer- Market Size & Forecast 2019-2029, USD Million

Others (Ovarian Cancer, Leukemia, etc.) - Market Size & Forecast 2019-2029, USD Million

According to report, The heightened presence of Lung Cancer patients globally has widely accumulated the demand for more effective diagnostic options over the past few years.

By Cell Type

Germline - Market Size & Forecast 2019-2029, USD Million

Somatic - Market Size & Forecast 2019-2029, USD Million

By End-User

Hospital & Clinics- Market Size & Forecast 2019-2029, USD Million

Research Institutes- Market Size & Forecast 2019-2029, USD Million

Diagnostic Laboratories- Market Size & Forecast 2019-2029, USD Million

Pharmaceutical and Biotechnology- Market Size & Forecast 2019-2029, USD Million

According to report, Research Institutes are poised to capture the potential share of the Global Cancer Gene Panel and Profiling Market in the coming years.

Explore the Complete Global Cancer Gene Panel and Profiling Analysis Report – https://www.marknteladvisors.com/research-library/cancer-gene-panel-profiling-market.html

Geographical Analysis: Global Cancer Gene Panel and Profiling

By Region

North America

South America

Europe

The Middle East & Africa

Asia-Pacific

The Global Cancer Gene Panel and Profiling Industry Recent Development:

2023: Neo Genomics and Massive Bio announced a collaboration to leverage their expertise in biomarker testing, data analysis, machine learning, and biomarker and genomic profiling to accomplish a significant milestone within the field of oncology.

2022: Variantyx invested USD 41.5 million for its advanced genomic testing platform, with plans to target growth in precision oncology.

Key Questions Addressed in This Study

What are the primary factors driving the growth of the Global Cancer Gene Panel and Profiling?

How is the Global Cancer Gene Panel and Profiling expected to evolve over the next five years?

What key insights can be drawn from current trends shaping the market?

What is the current market size, and how is it forecasted to change in the coming years?

What is the future outlook for the market in terms of technological innovation and geographic expansion?

For a Customized Analysis Report, Just Drop Your Inquiry Here – https://www.marknteladvisors.com/query/request-customization/cancer-gene-panel-profiling-market.html

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

More Research Studies Report:

-Biocomposites Market size was valued at around USD 36.9 billion in 2024 and is projected to reach USD 89 billion by 2030 with a CAGR of around 119.27%.

-Green Solvents Market size was valued at around USD 1.34 billion in 2024 & is projected to reach USD 1.87 billion by 2030 with a CAGR of around 5.7%.

For Media Inquiries, Please Contact:

Email: sales@marknteladvisors.com

Trending Blogs : www.marknteladvisors.com/blogs

Export-import Data : https://www.marknteladvisors.com/export-import-data